Continuous renal replacement therapy (CRRT) is an essential tool in the management of renal failure in patients who are critically ill. Though its utilization has increased globally, it is a resource-intensive, costlier modality of dialysis.1-4 Furthermore, its usage is highly variable owing to the heterogeneity of patients and physicians, as well as the paucity of evidence to guide practice.5 These characteristics make it a prime target for high-value care through standardization of practice. At our institution, we assessed utilization patterns of CRRT and established evidence-based guidelines to standardize process flow and promote meaningful use.
Tseng J, Halbert RJ, Minissian N, et al. Association of Standardization of Continuous Renal Replacement Therapy and High-Value CareAn Evidence-Based Approach. JAMA Intern Med. 2018;178(4):572–573. doi:10.1001/jamainternmed.2017.8732
Customize your JAMA Network experience by selecting one or more topics from the list below.